Andrew Zapp

Andrew Zapp is a seasoned professional in the precision medicine and oncology fields, currently serving as a Precision Medicine Executive at Blueprint Medicines since April 2025. Prior to this role, Andrew held positions including Territory Manager at Novocure from July 2024 to May 2025 and Oncology Account Executive at Guardant Health from September 2021 to June 2024. Andrew's experience also includes serving as Vice President of Sales & Marketing at CellNetix Pathology and Laboratories from March 2020 to September 2021 and Manager of Pathology Services at Caris Life Sciences from January 2019 to March 2020. Andrew earned a Bachelor of Science degree in Sociology and Business Administration from the University of Oregon, completing studies in January 2001.